Spots Global Cancer Trial Database for metastatic olfactory neuroblastoma
Every month we try and update this database with for metastatic olfactory neuroblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma | NCT06308575 | Metastatic Olfa... Recurrent Olfac... | Rivoceranib | 18 Years - | M.D. Anderson Cancer Center | |
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors | NCT06176989 | Metastatic Chon... Locally Advance... Metastatic Sino... Locally Advance... Metastatic Larg... Locally Advance... Metastatic Olfa... Locally Advance... Metastatic Sino... Locally Advance... | Enasidenib | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors | NCT06176989 | Metastatic Chon... Locally Advance... Metastatic Sino... Locally Advance... Metastatic Larg... Locally Advance... Metastatic Olfa... Locally Advance... Metastatic Sino... Locally Advance... | Enasidenib | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) |